Akouos Total Liabilities 2011-2026 | AKUS

Annual Total Liabilities Akouos

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
45.1 M	22.7 M	78 M	33 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
78 M	22.7 M	44.7 M

Quarterly Total Liabilities Akouos

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	44.7 M	46.6 M	47 M	45.1 M	41.2 M	40.1 M	25.1 M	22.7 M	22.7 M	22.7 M	22.7 M	19.3 M	19.3 M	19.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
47 M	19.3 M	31.3 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	705 M	$ 20.41	-1.4 %	$ 2.57 B	USA
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	4.35 M	$ 0.84	-	$ 4.58 M	China
Axsome Therapeutics AXSM	602 M	$ 164.26	-1.27 %	$ 8.17 B	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Burford Capital Limited BUR	1.45 B	$ 8.4	-3.78 %	$ 1.39 B	Britain
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	390 M	$ 3.69	-3.4 %	$ 1.1 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	36.1 M	$ 25.63	-4.59 %	$ 686 M	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Codexis CDXS	82.1 M	$ 1.01	-0.98 %	$ 74.1 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	387 M	$ 3.22	-3.59 %	$ 1.15 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	104 M	$ 28.11	-3.73 %	$ 1.63 B	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Завод ДИОД DIOD	195 M	-	-	-	Russia
Фармсинтез LIFE	1.04 B	-	-	-	Russia
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	253 M	$ 3.67	-3.42 %	$ 116 M	France
Alector ALEC	263 M	$ 2.12	-4.3 %	$ 218 M	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	7.8 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	15.8 M	$ 4.08	-1.92 %	$ 290 M	USA
Teligent, Inc. TLGT	198 M	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Viela Bio, Inc. VIE	47.4 M	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	211 M	$ 13.79	-1.01 %	$ 5.72 B	Irlanda
AbbVie ABBV	97.3 B	$ 233.58	-0.27 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	881 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
AIM ImmunoTech AIM	3.29 K	$ 0.75	-4.39 %	$ 36.1 M	USA
Corcept Therapeutics Incorporated CORT	189 M	$ 35.09	-2.45 %	$ 3.64 B	USA